drugset / Trial / NCT01565369

Evaluation of Physician Training Methods to Read Florbetapir-PET Scans

NCT01565369

Completed 35 enrolled Avid Radiopharmaceuticals
NaSingle-groupSingle-blindDiagnostic

Summary

The purpose of this study is re-read of brain amyloid positron emission tomography (PET) scans acquired in previous florbetapir F 18 clinical studies by readers trained using updated reading methodology. The scans in this study came from subjects who had an autopsy to reveal the subject's true amyloid status.

Timeline

Start
2011-01
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Background florbetapir Diagnostic / imaging agent 370 mbq Intravenous

Indications